Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Revenue

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹7,896 Cr₹6,658 Cr₹5,986 Cr₹5,855 Cr₹6,056 Cr

What is the latest Revenue of EMCURE PHARMACEUTICALS ?

The latest Revenue ratio of EMCURE PHARMACEUTICALS is ₹7,896 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹7,896 Cr
Mar2025₹6,658 Cr
Mar2024₹5,986 Cr
Mar2023₹5,855 Cr
Mar2022₹6,056 Cr

How is Revenue of EMCURE PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹7,896 Cr
18.59
Mar2025 ₹6,658 Cr
11.23
Mar2024 ₹5,986 Cr
2.23
Mar2023 ₹5,855 Cr
-3.32
Mar2022 ₹6,056 Cr -

Compare Revenue of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹33,779.9 Cr 0.9% -10.1% 31.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -0.1% -6.5% 3.8% Stock Analytics
DIVIS LABORATORIES ₹240,780.0 Cr -0.2% -5.5% 35.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,828.0 Cr 0.4% -8.2% 25.2% Stock Analytics
CIPLA ₹109,305.0 Cr 1.7% -2% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,759.0 Cr 4.9% 7.7% -2.5% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

0.9%

-10.1%

31.4%

SENSEX

-1.5%

-1.2%

-11.8%


You may also like the below Video Courses